| Market Capitalization (Millions $) |
557 |
| Shares
Outstanding (Millions) |
2 |
| Employees |
660 |
| Revenues (TTM) (Millions $) |
169 |
| Net Income (TTM) (Millions $) |
21 |
| Cash Flow (TTM) (Millions $) |
-26 |
| Capital Exp. (TTM) (Millions $) |
28 |
Atrion Corporation
Atrion Corporation is a healthcare company that focuses on developing and manufacturing medical devices and specialty products for various clinical applications. Established in 1944, the company was initially known as Allen-Simmons Corporation and later changed its name to Atrion Corporation in 1993, following a merger with Cardiovascular Products, Inc.
With its headquarters in Allen, Texas, Atrion Corporation has a significant global presence, with various subsidiaries and facilities in Canada, Europe, and Asia. The company has a diverse range of product lines, comprising of medical devices, intraocular lenses, inertial navigation systems, and other specialty products.
The medical device business unit of Atrion Corporation designs, develops, and manufactures a wide range of cardiovascular and fluid delivery products. These include catheters, valves, sheaths, introducers, and other devices used in diagnostic and interventional procedures. These devices offer healthcare professionals precise control and improved outcomes, making them the preferred choice in many clinical settings.
Additionally, Atrion Corporation's intraocular lens business unit focuses on the design and manufacturing of lenses used in cataract surgery. The lenses are made from high-quality materials that provide excellent optical clarity and patient comfort, leading to improved visual outcomes.
Another interesting aspect of Atrion Corporation's product line is its inertial navigation systems, which are used in the aerospace and defense industry. These systems are designed to provide accurate guidance and navigation information, making them critical components in various applications, including missile guidance, unmanned aerial systems, and spacecraft.
In terms of financials, Atrion Corporation generates revenues of approximately $155 million annually, with a net income of $38 million. The company is publicly traded on the NASDAQ stock exchange under the symbol "ATRI," and it has a market capitalization of approximately $1 billion.
Overall, Atrion Corporation is a healthcare company that has shown resilience and innovation, particularly in its medical device and intraocular lens product lines. Its dedication to precision, quality, and improved outcomes has made it a trusted name in the healthcare industry, positioning the company for continued growth and success.
Company Address: One Allentown Parkway Allen 75002 TX
Company Phone Number: 390-9800 Stock Exchange / Ticker: NASDAQ ATRI
| ATRI is expected to report next financial results on February 06, 2024. |
Next quarterly dividend pay out on December 15, 2023. |
|
